Related Experiment Videos
Riboflavin deficiency and severity of malaria
B S Das1, D B Das, R N Satpathy
1Ispat General Hospital, Orissa, India.
Insights
Riboflavin deficiency was observed in children with malaria, impacting their recovery. Lower parasite counts in deficient children suggest riboflavin may inhibit malaria parasite growth.
Area of Science:
- Nutritional Biochemistry
- Infectious Diseases
- Malariology
Background:
- Malaria remains a significant global health challenge, particularly in children.
- Riboflavin (vitamin B2) is essential for cellular metabolism and immune function.
- Nutritional status, including vitamin deficiencies, can influence malaria outcomes.
Purpose of the Study:
- To assess the riboflavin status of children with malaria.
- To investigate the relationship between riboflavin deficiency and malaria parasite load.
- To evaluate the impact of riboflavin status on malaria recovery.
Main Methods:
- Erythrocyte glutathione reductase activation coefficient was used to determine riboflavin status.
- Malaria parasite counts were quantified in children.
- Correlation analysis was performed between riboflavin status and parasite load.
Main Results:
- Riboflavin deficiency was identified in 35 out of 64 children.
- Children with riboflavin deficiency had lower median parasite counts upon admission.
- The recovery process was slower in riboflavin-deficient children.
Conclusions:
- Riboflavin deficiency may inhibit the growth and multiplication of Plasmodium parasites.
- Riboflavin status appears to influence the clinical course of malaria in children.
- Further research is warranted to evaluate the therapeutic potential of riboflavin in malaria management.
Abstract:
The riboflavin status of 64 children suffering from malarial infection was assessed by measuring the activation coefficient of erythrocyte glutathione reductase. Thirty-five children were found to be deficient in riboflavin whereas in 29 children riboflavin status was within the normal range. The median parasite count and its range on admission in the deficient group (2.7 per cent, range 0.3-13.6) was lower than that in the non-deficient group (5.3 per cent, range 0.6-30.2). The correlation between activity coefficient and parasite count was significant (R = -0.49). The recovery process was slower in the deficient group even though they had a relatively lower parasite count. It is inferred that riboflavin deficiency leads to inhibition of growth and multiplication of plasmodia. Its beneficial effects in malaria infection needs further evaluation.